Anavex Life Science (AVXL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec18

Anavex requests EMA to re-examine blarcamesine for Alzheimer's

12:30

Dec12

Anavex Life Sciences Corp's Alzheimer's drug application rejected by the EU

21:05

Nov25

Annavik Life Sciences Reports No Revenue in FY2025, Cash and Operating Funds Decline

21:33

Anavex Life Science released FY2025 Annual Earnings on November 25 During-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5437 (forecast USD -0.5766)

21:00

Anavex Life Science released FY2025 Q4 earnings during market hours on November 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1144 (forecast USD -0.15)

21:00

Nov19

Anavex Life Sciences Corp. is a biopharmaceutical company focused on developing innovative treatments for multiple diseases

13:33